| MMWR- Morbidity and Mortality Weekly Report MMWR News Synopsis for August 4, 2016
Disparities in Adult Cigarette Smoking — United States, 2002–2005 and 2010–2013 Proven interventions, including increasing the price of tobacco products, coupled with evidence-based cessation services, comprehensive smoke-free policies, high-impact media campaigns, and promotion of cessation treatment in clinical settings, are effective strategies in reducing the prevalence of tobacco use and tobacco-related disease and death in all racial/ethnic populations. To assess the prevalence of, and changes in, cigarette smoking among persons ages ≥18 years in six racial/ethnic populations and 10 select subgroups in the U.S., CDC analyzed self-reported data collected during 2002–2005 and 2010–2013 from the National Survey on Drug Use and Health and compared differences between the two periods. During 2010–2013, the overall prevalence of cigarette smoking among the racial/ethnic populations and subgroups ranged from 38.9 percent for American Indian/American Nativesto 7.6 percent for Chinese and Asian Indians. Differences might be due, in part, to variations in socioeconomic status, acculturation, targeted advertising, price of tobacco products, and practices related to the acceptability of tobacco use across population groups. These findings highlight the importance of looking at tobacco use estimates by smaller racial/ethnic subgroups and by sex to better understand and address disparities in tobacco use among U.S. adults.
CDC Grand Rounds: Adolescence — Preparing for Lifelong Health and Wellness Public health's role in understanding and addressing adolescent health is to provide adolescents with effective, accurate, and developmentally appropriate health promotion and disease prevention education and comprehensive health services. Such efforts require strategies and approaches that engage adolescents in the settings where they live, learn, and receive health care. Approximately 42 million adolescents ages 10-19 years, or about 13 percent of the population, live in the United States. Health in adulthood is often determined by health risk behaviors established during adolescence. Preventing the initiation of potentially harmful behaviors during adolescence can have lifelong health benefits. Supporting adolescents' health requires parents, schools, health care systems, and communities to help youth be healthy throughout their formative years. Family-based approaches can maximize the positive influences that parenting has on children by building parents' knowledge, skills, and confidence in communicating about risky behavior. Schools can offer quality health and physical education, nutrition and health services, and safe and supportive environments: all can help produce healthier students who are ready to learn. Health services can provide quality primary care services that are specifically tailored to the needs of adolescents: readily available and accessible, confidential, and welcoming and youth friendly.
Update on Vaccine-Derived Polioviruses — Worldwide, January 2015–May 2016 The ultimate goal of the Global Polio Eradication Initiative is the end of all poliovirus circulation. Circulating vaccine-derived polioviruses (cVDPVs), biologically equivalent to wild polioviruses, emerge in settings of low population immunity and can sustain long-term circulation. The risk of immunodeficiency-associated vaccine-derived polioviruse (iVDPV) emergence will continue as long as oral poliovirus vaccine (OPV) is used. The switch from trivalent OPV to bivalent OPV in April 2016 is the first step in phasing out the use of all OPV, setting the stage for a subsequent total worldwide shift from OPV to injectable inactivated poliovirus vaccine (IPV). Vaccine-derived polioviruses (VDPVs), are genetic divergent strains from OPV that fall into three categories: 1) cVDPVs from outbreaks, 2) iVDPVs from patients with primary immunodeficiencies, and 3) ambiguous VDPVs (aVDPVs) that cannot be more definitively identified. During January 2015–May 2016, Myanmar, Laos, Ukraine, and Guinea had new cVDPV outbreaks and Nigeria and Pakistan had sharply reduced cVDPV2 circulation. Twenty-one newly identified persons in 10 countries were found to excrete iVDPVs. Because >94 percent of cVDPVs since 2006 and 66 percent of iVDPVs since OPV introduction are type 2, WHO coordinated worldwide replacement of trivalent OPV with bivalent OPV (types 1 and 3) in April 2016.
Environmental Isolation of Circulating Vaccine-Derived Poliovirus after Interruption of Wild Poliovirus Transmission — Nigeria, 2016 Nigeria continues to make considerable progress toward polio eradication certification; however, recent VDPV isolation in Borno State highlights the difficulties of polio eradication in parts of the country affected by conflicts. Continued efforts to identify and vaccinate unreached children and to improve surveillance in and around Borno State remain an urgent public health priority. On April 29, 2016, laboratory-confirmed vaccine-derived poliovirus type 2 (VDPV2), a type of the oral polio vaccine virus that can cause paralysis, was reported in Maiduguri, Borno State, Nigeria. Further laboratory tests showed that the virus had been circulating undetected for about two years. Borno State, located in North East Nigeria, has experienced armed insurgency for the past seven years, which has limited polio eradication activities such as surveillance and immunization. The Nigeria Polio Emergency Operations Center started outbreak response activities following the reports of the VDPV.
Notes from the Field
QuickStats:
###
U.S. Department of Health and Human Services
CDC works 24/7 protecting America's health, safety and security. Whether diseases start at home or abroad, are curable or preventable, chronic or acute, stem from human error or deliberate attack, CDC is committed to respond to America's most pressing health challenges.
|
Thursday, August 4, 2016
CDC MMWR News Synopsis for Augusst 1, 2016
CDC Press Release: National ALS Registry Releases Updated Prevalence Estimates
| Press Release
Thursday, August 4, 2016
Contact: CDC Media Relations (404) 639-3286
National ALS Registry Releases Updated Prevalence Estimates
The Agency for Toxic Substances and Disease Registry's (ATSDR) National ALS Registry today released its second report on the prevalence of amyotrophic lateral sclerosis (ALS, commonly known as Lou Gehrig's disease) in the United States for the years 2012 and 2013. The report shows the Registry identified 14,713 and 15,908 people, respectively, who met the surveillance case definition of ALS. The estimated ALS prevalence rate was 4.7 cases per 100,000 U.S. population for 2012 and 5.0 cases per 100,000 for 2013.
"It is likely the increased prevalence rate since the first report was issued does not reflect an actual increase in the number of ALS cases. Rather, this increase is more attributable to better detection methods used to identify ALS cases, along with an increased public awareness of the Registry," said Paul Mehta, M.D., medical epidemiologist and principal investigator, National ALS Registry, and lead author of the report.
ALS was more common among whites, males, and people ages 60–69 years. The age groups with the lowest number of ALS cases were people ages 18–39 years and those ≥80 years. Males had a higher prevalence rate of ALS than females overall and across all data sources. These findings remained consistent between October 2010–December 2013 and are similar to findings from long-established ALS registries in Europe and from smaller-scale epidemiologic studies previously conducted in the United States.
### U.S. Department of Health and Human Services
CDC works 24/7 saving lives and protecting people from health threats to have a more secure nation. Whether these threats are chronic or acute, manmade or natural, human error or deliberate attack, global or domestic, CDC is the U.S. health protection agency.
|
CDC Press Release: Some racial, ethnic groups continue smoking cigarettes at higher rates
| Press Release
Thursday, August 4, 2016
Contact: CDC Media Relations (404) 639-3286
Some racial, ethnic groups continue smoking cigarettes at higher rates Substantial disparities found among American Indians/Alaska Natives, Korean and Puerto Rican Americans Despite a significant decline in overall adult cigarette smoking since 1964, disparities in cigarette smoking remain among racial and ethnic population groups, according to a new study from the Centers for Disease Control and Prevention (CDC) published in today's Morbidity and Mortality Weekly Report (MMWR). For example, current (past 30-day) cigarette smoking during 2010-2013 was lower among Asians overall (10.9 percent) compared with Whites (24.9 percent). But among Asian sub-groups, the prevalence of current cigarette smoking ranged from 7.6 percent among Chinese and Asian Indians to 20.0 percent among Korean Americans. The American Indian/Alaska Native population had the highest prevalence of cigarette smoking at 38.9 percent. The findings in this study show the importance of identifying higher rates of tobacco use across and within racial/ethnic population groups to better understand and address differences in tobacco use among U.S. adults. Larger sample size for racial/ethnic subgroups Estimates of cigarette smoking prevalence are usually presented in aggregate for racial or ethnic populations, such as Asian or Hispanic, because sample sizes are too small to provide estimates among racial/ethnic subgroups within these populations. To get a large enough sample size for this study, researchers aggregated data from the National Survey on Drug Use and Health collected between 2002-2005 and 2010-2013 to assess cigarette-smoking prevalence among 6 racial and ethnic population groups and 10 select subgroups in the United States. "Even though the overall cigarette-smoking rate is declining, disparities remain among racial and ethnic groups and within subgroups," said Bridgette Garrett, Ph.D., associate director for health equity in the CDC's Office on Smoking and Health. "Looking beyond broad racial and ethnic population categories can help better focus the strategies that we know work to reduce tobacco use among sub-groups with higher rates of use."
###
U.S. Department of Health and Human Services
CDC works 24/7 protecting America's health, safety and security. Whether diseases start at home or abroad, are curable or preventable, chronic or acute, stem from human error or deliberate attack, CDC is committed to respond to America's most pressing health challenges.
|
2016-08-04 14:15:11 (M6.0) JUJUY, ARGENTINA -22.4 -66.0 (442af)
M6.0 - JUJUY, ARGENTINA
| Magnitude | 6.0 |
| Date-Time |
|
| Location | 22.385S 65.994W |
| Depth | 258 km |
| Distances |
|
| Location Uncertainty | Horizontal: 6.3 km; Vertical 5.0 km |
| Parameters | Nph = 110; Dmin = 233.0 km; Rmss = 1.15 seconds; Gp = 28° Version = |
| Event ID | us 10006a1d |
For updates, maps, and technical information, see: Event Page or USGS Earthquake Hazards Program
Disclaimer
This email was sent to filter@clubhouseb.com
You requested mail for events between -90.0/90.0 latitude and 180.0/-180.0 longitude (world)
for M6.0 at all times.
To change your parameters, go to:
https://sslearthquake.usgs.gov/ens
To unsubscribe, send a one-line reply to this message with:
STOP filter@clubhouseb.com
Wednesday, August 3, 2016
News From CPSC: 1 Recall Announced Today
-----------NEWS from CPSC-----------
U.S. Consumer Product Safety Commission
Office of Communications
4330 East West Highway, Bethesda, MD 20814
www.cpsc.gov
1. Porta Recalls Residential Elevators Due to Serious Fall Hazard
http://www.cpsc.gov/en/Recalls/2016/Porta-Recalls-Residential-Elevators/
*************************************************************************************************************************************************************************************************************
1. Porta Recalls Residential Elevators Due to Serious Fall Hazard
http://www.cpsc.gov/en/Recalls/2016/Porta-Recalls-Residential-Elevators/
Recall Date: August 3, 2016
Recall Number: 16-238
Porta Recalls Residential Elevators Due to Serious Fall Hazard
http://www.cpsc.gov/en/Recalls/2016/Porta-Recalls-Residential-Elevators/
Recall Summary
Name of Product: Residential elevators with electro mechanical door locks (EMDLs)
Hazard: The plastic locks can allow the landing door to open before the elevator car arrives, posing a serious fall hazard to consumers attempting to board the elevator.
Remedy: Replace
Consumers should immediately stop using elevators equipped with the electro mechanical door locks and contact their elevator service company to have the plastic locks replaced with metal parts.
Consumer Contact: Consumers should contact their elevator service company. Consumers can also contact Porta Inc. toll-free at 844-719-9037 from 8 a.m. to 1 p.m. CT Monday through Thursday or online at www.emiporta.com and click on “Important Product Safety Notice” for more information. Consumers also can email the firm at emdlinfo@emiporta.com.
Recall Details
Photos Available At http://www.cpsc.gov/en/Recalls/2016/Porta-Recalls-Residential-Elevators/
Units: About 60,000
Description: This recall involves all residential elevators with plastic electro mechanical door locks. The EMDLs are installed as part of a complete residential elevator system. Locks included in this recall have a plastic generation 1, 2, 3 or 4 latch and keeper attached to the upper corner on the elevator side of each landing door. A UL or ETL label affixed to the bottom of the EMDL box has “Porta Inc.” printed on it.
Incidents/Injuries: The firm has received two reports of lock failure. No injuries have been reported.
Sold by: Elevator manufacturers nationwide from January 2005 through December 2011 for between $20,000 and $40,000.
Manufacturer: Porta Inc., of Arlington Heights, Ill.
Manufactured in: U.S.
*************************************************************************************************************************************************************************************************************
********************************************************
The U.S. Consumer Product Safety Commission (CPSC) is still interested in receiving incident or injury reports that are either directly related to a product recall or involve a different hazard with the same product. Please tell us about your experience with the product on SaferProducts.gov.
Media Contact
Please use the phone numbers below for all media requests.
Phone: (301) 504-7908
Spanish: (301) 504-7800
CPSC Consumer Information Hotline
Contact us at this toll-free number if you have questions about a recall:
800-638-2772 (TTY 301-595-7054)
Times: 8 a.m. � 5:30 p.m. ET; Messages can be left anytime
Call to get product safety and other agency information and to report unsafe products.
-----------------------------
You are currently subscribed to the e-mail list "recalls" as: filter@clubhouseb.com
To unsubscribe, please do one of the following:
(1) go to https://www.cpsc.gov/cpsclist.aspx and use the on-line form or
(2) send a blank email to leave-3053143-722517.ab849b11e0910fe06f56217347f10a65@list.cpsc.gov
You can also go to http://www.cpsc.gov/en/Newsroom/Subscribe/ to change your
subscription, or unsubscribe an old address and subscribe a new one.
This message is from the U.S. Consumer Product Safety Commission (www.cpsc.gov),
an independent federal regulatory agency, located at 4330 East West
Highway, Bethesda, MD 20814 Toll-free hotline: (800) 638-2772.
Teva Pharmaceuticals Initiates Voluntary Nationwide Recall of Seven Lots of Amikacin Sulfate Injection USP 500 mg/2 mL (250 mg/mL) and 1 Gram/4 mL (250 mg/mL) Vials Due to Potential of Glass Particulate Matter
You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).
This information has recently been updated and is now available.
For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.
| This email was sent to filter@clubhouseb.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332) |  |
CDC Media Statement: CDC adds Antigua and Barbuda and Turks and Caicos Islands (U.K.) to interim travel guidance related to Zika virus
| Media Statement
Wednesday, August 3, 2016
Contact: CDC Media Relations 404-639-3286
CDC adds Antigua and Barbuda and Turks and Caicos Islands (U.K.) to interim travel guidance related to Zika virus
CDC is working with other public health officials to monitor for ongoing Zika virus transmission. Today, CDC posted a Zika virus travel notice for Antigua and Barbuda as well as Turks and Caicos Islands (U.K.). CDC has issued travel notices (level 2, "practice enhanced precautions") for people traveling to destinations with Zika. For a full list of affected countries/regions, visit http://wwwnc.cdc.gov/travel/page/zika-travel-information.
As more information becomes available, CDC's travel notices will be updated. Travelers to areas with cases of Zika virus infection are at risk of being infected with the Zika virus. Mosquitoes that spread Zika are aggressive daytime biters. They also bite at night. There is no vaccine or medicine for Zika virus. The best way to avoid Zika virus infection is to prevent mosquito bites.
Some travelers to areas with Zika will become infected while traveling but will not become sick until they return home and they might not have any symptoms. To help stop the spread of Zika, travelers should use insect repellent for three weeks after travel to prevent mosquito bites.
Some people who are infected do not have any symptoms. People who do have symptoms have reported fever, rash, joint pain, and red eyes. The sickness is usually mild with symptoms that last from several days to a week. Severe disease requiring hospitalization is uncommon and the number of deaths is low. Travelers to areas with Zika should monitor for symptoms or sickness upon return. If they become sick, they should tell their healthcare professional when and where they have traveled.
CDC has received reports of Zika virus being spread by sexual contact with sick returning travelers. Until more is known, CDC continues to recommend that pregnant women and women trying to become pregnant take the following precautions.
Pregnant women
*Barriers that prevent passing Zika through sex include male and female condoms and dental dams. Dental dams are latex or polyurethane sheets used between the mouth and vagina or anus during oral sex.
Women trying to get pregnant
For additional information on preventing the sexual transmission of Zika, visit www.cdc.gov/zika/transmission/sexual-transmission.html.
Current CDC research suggests that GBS is strongly associated with Zika; however, only a small proportion of people with recent Zika virus infection get GBS. CDC is continuing to investigate the link between GBS and Zika to learn more.
For more information on Zika, visit www.cdc.gov/zika.
###
U.S. Department of Health and Human Services
CDC works 24/7 protecting America's health, safety and security. Whether diseases start at home or abroad, are curable or preventable, chronic or acute, stem from human error or deliberate attack, CDC is committed to respond to America's most pressing health challenges.
|
